Dose-Escalated Intensity Modulated Radiation Therapy for Prostate Cancer: 15-Year Outcomes Data

Zietman, 2005, Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial, JAMA, 294, 1233, 10.1001/jama.294.10.1233 Zelefsky, 2002, High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients, Int J Radiat Oncol Biol Phys, 53, 1111, 10.1016/S0360-3016(02)02857-2 Zelefsky, 2006, Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer, J Urol, 176, 1415, 10.1016/j.juro.2006.06.002 Pollack, 2002, Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial, Int J Radiat Oncol Biol Phys, 53, 1097, 10.1016/S0360-3016(02)02829-8 Pollack, 2004, Prostate cancer radiotherapy dose response: An update of the fox chase experience, J Urol, 171, 1132, 10.1097/01.ju.0000111844.95024.74 Peeters, 2006, Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy, J Clin Oncol, 24, 1990, 10.1200/JCO.2005.05.2530 Dearnaley, 2014, Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: Long-term results from the MRC RT01 randomised controlled trial, Lancet Oncol, 15, 464, 10.1016/S1470-2045(14)70040-3 Cahlon, 2008, Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: Toxicity and biochemical outcomes, Int J Radiat Oncol Biol Phys, 71, 330, 10.1016/j.ijrobp.2007.10.004 Zelefsky, 2011, Dose escalation for prostate cancer radiotherapy: Predictors of long-term biochemical tumor control and distant metastases-free survival outcomes, Eur Urol, 60, 1133, 10.1016/j.eururo.2011.08.029 Zelefsky, 2012, Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer, Int J Radiat Oncol Biol Phys, 84, 125, 10.1016/j.ijrobp.2011.11.047 Spratt, 2013, Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, 85, 686, 10.1016/j.ijrobp.2012.05.023 Alicikus, 2011, Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer, Cancer, 117, 1429, 10.1002/cncr.25467 Zelefsky, 2001, High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer, J Urol, 166, 876, 10.1016/S0022-5347(05)65855-7 Zelefsky, 2000, Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer, Radiother Oncol, 55, 241, 10.1016/S0167-8140(99)00100-0 Burman, 1997, Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: A strategy for large-scale implementation for the treatment of carcinoma of the prostate, Int J Radiat Oncol Biol Phys, 39, 863, 10.1016/S0360-3016(97)00458-6 Chui, 2001, Inverse planning algorithms for external beam radiation therapy, Med Dosim, 26, 189, 10.1016/S0958-3947(01)00069-3 Mohan, 1994, The potential and limitations of the inverse radiotherapy technique, Radiother Oncol, 32, 232, 10.1016/0167-8140(94)90023-X Kuban, 2008, Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer, Int J Radiat Oncol Biol Phys, 70, 67, 10.1016/j.ijrobp.2007.06.054 Zietman, 2010, Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09, J Clin Oncol, 28, 1106, 10.1200/JCO.2009.25.8475 Heemsbergen, 2014, Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival, Radiother Oncol, 110, 104, 10.1016/j.radonc.2013.09.026 Beckendorf, 2011, 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial, Int J Radiat Oncol Biol Phys, 80, 1056, 10.1016/j.ijrobp.2010.03.049 Michalski, 2018, Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: The NRG oncology RTOG 0126 randomized clinical trial, JAMA Oncol, 4, e180039, 10.1001/jamaoncol.2018.0039 Al-Mamgani, 2008, Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer, Int J Radiat Oncol Biol Phys, 72, 980, 10.1016/j.ijrobp.2008.02.073 Syndikus, 2010, Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: Results from the UK Medical Research Council RT01 trial (ISRCTN47772397), Int J Radiat Oncol Biol Phys, 77, 773, 10.1016/j.ijrobp.2009.05.052 Zelefsky, 2012, Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer, Int J Radiat Oncol Biol Phys, 83, 953, 10.1016/j.ijrobp.2011.08.034 Singh, 2005, Higher than expected association of clinical prostate and bladder cancers, J Urol, 173, 1526, 10.1097/01.ju.0000154700.80042.c6 Pickles, 2002, The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984–2000, Radiother Oncol, 65, 145, 10.1016/S0167-8140(02)00307-9 Huvos, 1985, Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients, Cancer, 55, 1244, 10.1002/1097-0142(19850315)55:6<1244::AID-CNCR2820550617>3.0.CO;2-1 Cahan, 1948, Sarcoma in irradiated bone. Report of eleven cases, Cancer, 1, 3, 10.1002/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7 Mark, 1994, Postirradiation sarcomas. A single-institution study and review of the literature, Cancer, 73, 2653, 10.1002/1097-0142(19940515)73:10<2653::AID-CNCR2820731030>3.0.CO;2-G